LIU Yanjun
Guangdong Cardiovascular Institute & Guangdong Provincial People’s Hospital & Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, ChinaWEI Peijian
Shantou University Medical College, Shantou, Guangdong 515041, ChinaHUANG Zhiqi
School of Biology and Biological Engineering, South China University of Technology, Guangzhou, Guangdong 510006, ChinaGUO Jishen
The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong 510280, ChinaCHEN Zerun
The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong 510280, ChinaZHU Jiening
Guangdong Cardiovascular Institute & Guangdong Provincial People’s Hospital & Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, ChinaXU Jindong
Guangdong Cardiovascular Institute & Guangdong Provincial People’s Hospital & Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, ChinaSHAN Zhixin
Guangdong Cardiovascular Institute & Guangdong Provincial People’s Hospital & Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, China;School of Biology and Biological Engineering, South China University of Technology, Guangzhou, Guangdong 510006, China;The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong 510280, ChinaGUO Huiming
Guangdong Cardiovascular Institute & Guangdong Provincial People’s Hospital & Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, China1.Guangdong Cardiovascular Institute & Guangdong Provincial People’s Hospital & Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, China;2.Shantou University Medical College, Shantou, Guangdong 515041, China;3.School of Biology and Biological Engineering, South China University of Technology, Guangzhou, Guangdong 510006, China;4.The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong 510280, China)
R363
LIU Yanjun, WEI Peijian, HUANG Zhiqi, GUO Jishen, CHEN Zerun, ZHU Jiening, XU Jindong, SHAN Zhixin, GUO Huiming. Study on overexpression of methyltransferase-like 3 promoting myocardial fibrosis[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2022,30(6):476-482.
Copy